Sanofi-Aventis To Launch Generic Allegra To Battle Risky Patent Challenge
Drug maker Sanofi-Aventis SA will launch an authorized generic version of the allergy pill Allegra in the U.S. to fight off competition from rival drug makers, which shocked analysts earlier this...To view the full article, register now.
Already a subscriber? Click here to view full article